Itacitinib in advanced hepatocellular cancer following first line therapy
- DOI
- 10.1038/s41698-026-01273-9
- Published
- 2026-02-11
- Container
- npj Precision Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-026-01273-9,
title = {Itacitinib in advanced hepatocellular cancer following first line therapy},
author = {Alessandro Troiani and Lingshan Hung and David J. Pinato and Maria Martinez and Debashish Sarker and Caroline Ward and Hooshang Izadi and Rob Goldin and Mathew Vithayathil and Sultan Alharbi and Haonan Lu and Rohini Sharma},
year = {2026},
journal = {npj Precision Oncology},
doi = {10.1038/s41698-026-01273-9},
url = {https://doi.org/10.1038/s41698-026-01273-9}
}RIS
TY - JOUR TI - Itacitinib in advanced hepatocellular cancer following first line therapy AU - Alessandro Troiani AU - Lingshan Hung AU - David J. Pinato AU - Maria Martinez AU - Debashish Sarker AU - Caroline Ward AU - Hooshang Izadi AU - Rob Goldin AU - Mathew Vithayathil AU - Sultan Alharbi AU - Haonan Lu AU - Rohini Sharma PY - 2026 JO - npj Precision Oncology DO - 10.1038/s41698-026-01273-9 UR - https://doi.org/10.1038/s41698-026-01273-9 ER -
APA
Troiani, A., Hung, L., Pinato, D. J., Martinez, M., Sarker, D., Ward, C., Izadi, H., Goldin, R., Vithayathil, M., Alharbi, S., Lu, H., & Sharma, R. (2026). Itacitinib in advanced hepatocellular cancer following first line therapy. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01273-9
Source records
- crossref · retrieved 2026-09-27T09:11:22.468Z